REFYME
Live / Applied — Second extension granted (statement of use) (as of 16 Mar 2026)
What this means for you
Not registered yet, but its 16 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98753168
- Mark type
- Stylized text
- Filed
- 16 Sept 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Felicia J. Boyd
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of memory disorders, cognition disorders, neurological disorders, neurodegenerative disorders, dementia and Alzheimer's disease; pharmaceutical preparations in the nature of a neuroprotective agent
Owner
- Cerecin Inc., Denver, CO, US
- Cerecin Inc., Denver, CO, US
Prosecution history
- 17 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2026 — SOU EXTENSION 2 GRANTED
- 16 Mar 2026 — SOU EXTENSION 2 FILED
- 16 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2025 — SOU EXTENSION 1 GRANTED
- 24 Nov 2025 — SOU EXTENSION 1 FILED
- 24 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Mar 2025 — ASSIGNED TO EXAMINER
- 16 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED